X 
Company News
Home | Market Info | Company Profile | Company News
Dr. Reddy's Laboratories Ltd.
BSE CODE: 500124   |   NSE CODE: DRREDDY   |   ISIN CODE : INE089A01023   |   14-May-2024 10:42 Hrs IST
BSE NSE
Rs. 5887.65
-30.9 ( -0.52% )
 
Prev Close ( Rs.)
5918.55
Open ( Rs.)
5949.90
 
High ( Rs.)
5949.90
Low ( Rs.)
5858.10
 
Volume
2965
Week Avg.Volume
15878
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 5880.00
-28.55 ( -0.48% )
 
Prev Close ( Rs.)
5908.55
Open ( Rs.)
5938.90
 
High ( Rs.)
5945.40
Low ( Rs.)
5858.00
 
Volume
69163
Week Avg.Volume
455316
 
52 WK High-Low Range(Rs.)
4384.05
6505.9
08-May-2024 Dr. Reddy’s Laboratories informs about audio recordings of earnings call
08-May-2024 LTIMindtree, Kajaria Ceramics and Piramal Pharma to see some action today
07-May-2024 Dr. Reddy's Laboratories reports 36% rise in Q4 consolidated net profit
03-May-2024 Dr. Reddy's Laboratories launches Doxycycline Capsules
25-Apr-2024 Dr. Reddy’s, Nestle India enter into definitive agreement to form joint venture
24-Apr-2024 Dr. Reddy’s issues voluntary nationwide recall of Sapropterin Dihydrochloride Powder for Oral Solution
19-Apr-2024 Dr.Reddy's Laboratories submits certificate
15-Apr-2024 Dr. Reddy’s Laboratories’ arm to sell entire stake in Dr. Reddy’s Venezuela C.A., Venezuela
10-Apr-2024 Dr. Reddy’s launches drug-free migraine management wearable device Nerivio in Germany
05-Apr-2024 Dr. Reddy's, Bayer sign marketing, distribution agreement for second brand of Vericiguat in India
Page 1 of 8
PREV || NEXT